WebPeripheral blood counts should be performed at regular intervals for the duration of cisplatin treatment. Anaphylaxis Reactions, possibly secondary to cisplatin therapy, have been occasionally reported in patients who were previously exposed to cisplatin. Patients who are at particular risk are those with a prior history or family history of atopy. WebFeb 24, 2024 · Certain chemotherapy medications, such as cisplatin, can cause damage to the kidneys and bladder. This can result in a decreased ability of your kidneys to filter your blood. Damage to the bladder can also occur and may be temporary or permanent. Symptoms of bladder irritation may include pain or urgency with urination, or blood in …
Hydration regimens for cisplatin - Oncology Nurse Advisor
WebDec 1, 2024 · Methods. In this open-label, randomized, phase III study, newly diagnosed patients with advanced NSCLC were initially randomized (R1, 1:1) to receive first-line treatment with cisplatin 75 mg/m 2 plus docetaxel 75 mg/m 2 (DC75) or 60 mg/m 2 (DC60) for up to 4 cycles. Patients without progression were further randomized (R2, 1:2) to best … WebJan 11, 2024 · At follow-up (median duration 6 years), ... Following cisplatin treatment, ongoing nephrology care and follow-up is recommended for patients with impaired renal … highway freight center
Cisplatin nephrotoxicity - UpToDate
WebEach cycle varies depending on what type of cancer you have. You might have cisplatin: every 3 or 4 weeks once a week every day over a 5 day period, every 3 to 4 weeks You … WebMar 14, 2024 · Usual Adult Dose for Non-Small Cell Lung Cancer 28-Day Schedule: 1000 mg/m2 IV over 30 minutes on Day 1, 8, and 15 in combination with cisplatin 100 mg/m2 IV on Day 1 after gemcitabine administration 21-Day Schedule: 1250 mg/m2 IV over 30 minutes on Day 1 and 8 in combination with cisplatin 100 mg/m2 IV on Day 1 after … WebApr 16, 2024 · The median duration of response was 11.2 months (range, 1.1+ to 18.0+) in the pembrolizumab-combination group and 7.8 months (range, 2.1+ to 16.4+) in the placebo-combination group. (Plus signs... highway freeway 違い